News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Daily News Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation Todd Neale June 14, 2023
News Daily News Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis Todd Neale March 02, 2021
News Daily News CV Complications of Malaria Rare but Portend Poor Prognosis Michael O'Riordan February 22, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Daily News Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines Todd Neale January 29, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk Yael L. Maxwell November 28, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016